CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- 4 Grant or award Chief Financial Officer acquired 50,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 17,578 shares (grant or award)
- 4 Grant or award Director acquired 8,789 shares (grant or award)
- 4 Grant or award Director acquired 17,578 shares (grant or award)
- 4 Option exercise Executive Chairman acquired 47,333 shares (option exercise)
- 4 Open-market sale President and CEO sold 11,656 shares at $1.45 ($16,901)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CBFO sold 8,541 shares at $1.45 ($12,384)
- 4 Derivatives Options or other derivatives
- 4 Conversion CEO acquired 71,000 shares (conversion)
- 4 Conversion 10% owner acquired 1,250,000 shares (conversion)
- 4 Derivatives Options or other derivatives
Page 1 of 10 · 182 filings